FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Healthcare & Life Sciences Enterprise Capital Monitor – Europe 06/2024”. The Monitor is a month-to-month revealed overview of enterprise capital developments within the European Healthcare & Life Sciences sector.
As of the tip of June 2024 we establish the next present VC developments in Europe:
-
Whole Healthcare & Life Sciences funding reached EUR 4,110m.
-
Biotech acquired 59% of the overall funding quantity (EUR 2,439m) with oncology being the main indication (50%).
-
In June, Shiny Peak Therapeutics (Switzerland) secures the very best transaction quantity with EUR 83m, adopted by iOnctura (Switzerland) with EUR 80m and UroMems (France) with EUR 44m.
-
European Innovation Council Fund (Belgium) is probably the most lively investor (by deal quantity), adopted by M&G Investments (United Kingdom) and Affected person Sq. Capital (United States).
To entry the total report, please click on right here.
